Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders.
Use of Cannabinoids for Spasticity and Pain Management in MS.
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
Interferon alpha association with neuromyelitis optica.
Environmental enrichment and brain repair: Harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity.
Meningoencephalitis-like onset of post-infectious AQP4-IgG-positive optic neuritis complicated by GM1-IgG-positive acute polyneuropathy.
Sunlight exposure and multiple sclerosis in a tropical country.
The Relationship Between Familial Mediterranean Fever Gene (MEFV) Mutations and Clinical and Radiological Parameters in Multiple Sclerosis Patients.
Coenzyme Q10 supplementation and multiple sclerosis.
Estimation of the multiple sclerosis risk in population living on contaminated territories after the Chornobyl catastrophe.
Bioconcentration, metabolism and neurotoxicity of the organophorous flame retardant 1,3-dichloro 2-propyl phosphate (TDCPP) to zebrafish.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
[Assessment of the effectiveness and safety of Sativex ® in compassionate use].
Semaphorin4A Is Cytotoxic to Oligodendrocytes and Is Elevated in Microglia and Multiple Sclerosis.
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review.
Costs and quality of life in multiple sclerosis patients with spasticity.
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
Vaccination-induced bilateral optic neuritis: rare but existing.
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.
Recovery of peripheral muscle function from fatiguing exercise and daily physical activity level in patients with multiple sclerosis: A case-control study.
Axonal transport rate decreased at the onset of optic neuritis in EAE mice.
Pages
« first
‹ previous
…
567
568
569
570
571
572
573
574
575
…
next ›
last »